C E Freise1, T Liu, N L Ascher
1Liver Transplant Division, University of California, San Francisco, 94143-0780, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Hepatocellular carcinoma recurrence after liver transplant is common. A new protocol using a hepatotoxin, pyrazofurin, significantly reduced metastatic disease in a rat model, offering a promising strategy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: